Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DX25F6SUF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $120,193
Award facts
- Contract value 100% obligated
- $120,192.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency Medical Supply Chain for the supply of Ocrevus 300 mg/10 mL vials. The contract is valued at $120,192.80 under a firm fixed-price arrangement with an ultimate completion date of August 25, 2025. This non-competitive delivery order was issued as a child contract against a larger vehicle, leveraging AmerisourceBergen's established relationship with federal medical procurement. The place of performance is located at the company's corporate office in Conshohocken, Pennsylvania.
This delivery order represents a continuation of AmerisourceBergen Drug Corp's extensive pharmaceutical supply role supporting the Defense Department's medical needs. The company holds a significant indefinite delivery contract (SPE2DX) valued at $999,999,999.00 with the DLA Troop Support Medical through December 2026, which serves as the overarching vehicle for global pharmaceutical support to military healthcare systems. Ocrevus, a specialty pharmaceutical product used for treating multiple sclerosis and other autoimmune conditions, exemplifies the category of critical brand-name medications that AmerisourceBergen supplies to support Defense Health Agency operations and other federal healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the operational requirements of federal medical supply chains serving military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DX25F6SUF?
SPE2DX25F6SUF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 4, 2025.
How much is contract SPE2DX25F6SUF worth?
The government has obligated $120,193 on SPE2DX25F6SUF.
Is contract SPE2DX25F6SUF an order under another contract?
Yes. SPE2DX25F6SUF is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6SUF competed?
The extent of competition for SPE2DX25F6SUF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award